• By ICR Secretariat
  • Posted Thursday, August 26, 2021

With new Fate data, same promise, questions surround 'natural killer' cell therapy

https://www.biopharmadive.com/news/fate-therapeutics-lymphoma-nk-cell-therapy-results/605322/

  • Fate Therapeutics reported new results for two early-stage studies testing two different types of experimental lymphoma treatments that utilize natural killer cells, a fast-emerging form of cancer immunotherapy.